Image

U.S. Topical Derma Drugs Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

U.S. Topical Derma Drugs Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Feb 2023
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

U.S. Topical Derma Drugs Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 4.70 USD million
Diagram Market Size (Forecast Year) USD 9.37 USD million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

U.S. Topical Derma Drugs Market, By Severity (Mild to Moderate, Moderate to Severe), Drug Class (Anti-Fungal, Corticosteroids, Local Anaesthetics, Anti-Virals, Antibiotics, Anti-Acne Agents, Anti-Itch Agents, Miscellaneous Topical Agents, Others), Formulation (Patches, Gel, Ointment, Cream, Foams, Others), Site (Surface of the Skin, Epidermis andDermis), Application (Acne, Cold Sores, Hives, Actinic Keratosis, Carbuncle, Rosacea, Eczema, Psoriasis, Lupus, Contact Dermatitis, Vitiligo, Warts, Ringworm, Impetigo and Others), Population Type (Children, Adults), Mode of Purchase (Prescription, Over the Counter (OTC)), End User (Hospitals, Specialty Clinics, Academic & Research Institutes and Others) – Industry Trends and Forecast to 2030.

U.S. Topical Derma Drugs Market Analysis and Size

Surge in R&D investment in the recent past has slowly increased the potential drugs candidate which is expected to drive the topical derma drugs market in the forecast period 2023-2030. Increasing prescription for generic drugs in the U.S. enables more new market players primary focusing on marketing generics, thus acting as a major driver for the growth of the market. The increasing initiatives by governments and private organizations to develop the pharmaceutical industry are boosting the growth of the market.

Data Bridge Market Research analyses a growth rate in the topical derma drugs market in the forecast period 2023-2030. The expected CAGR of topical derma drugs market is tend to be around 9% in the mentioned forecast period. The market value is USD 4.7 billion in 2022, and it would grow upto USD 9.37 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

U.S. Topical Derma Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Severity (Mild to Moderate, Moderate to Severe), Drug Class (Anti-Fungal, Corticosteroids, Local Anaesthetics, Anti-Virals, Antibiotics, Anti-Acne Agents, Anti-Itch Agents, Miscellaneous Topical Agents, Others), Formulation (Patches, Gel, Ointment, Cream, Foams, Others), Site (Surface of the Skin, Epidermis andDermis), Application (Acne, Cold Sores, Hives, Actinic Keratosis, Carbuncle, Rosacea, Eczema, Psoriasis, Lupus, Contact Dermatitis, Vitiligo, Warts, Ringworm, Impetigo and Others), Population Type (Children, Adults), Mode of Purchase (Prescription, Over the Counter (OTC)), End User (Hospitals, Specialty Clinics, Academic & Research Institutes and Others), Distribution Channel (Retail Pharmacy & Drug Store, Hospital Pharmacy, Online Pharmacy, Others)

Market Players Covered

Sanofi (France), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Amgen inc. (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), Johnson & Johnson Private Limited (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc (U.S.), Bausch Health Companies Inc (Canada) and Bristol-Myers Squibb Company (U.S.), Takeda Pharmaceutical Company Limited (Japan)

Market Opportunities

  • Increasing Cases of Skin Disorders

Market Definition

Topical derma drugs are the kind of products which are applied topically to the skin. Such drugs are largely used for the recovery of skin diseases and are frequently used to prevent some skin disorders. Though, dermatological are extensively used to protect the skin for a regular skin care. Derma drugs are categorized into anti-fungal, corticosteroids, local anaesthetics, anti-virals, antibiotics, anti-acne agents, anti-itch agents, miscellaneous topical agents.

U.S. Topical Derma Drugs Market Dynamics

Drivers

  • Increasing Elderly Population

Aged population loses the ability to function properly with increasing age, leading to numerous skin illnesses. Furthermore, as the person ages, the body starts to suffer from numerous additional issues, including high sensitivity to ultraviolet (UV) radiation, more susceptibility to infections, slower wound healing, and decreased subcutaneous fat. The growing need for dermatological medications has increased because of the increased likelihood of many skin conditions.

  • Increasing Government Initiatives

The initiatives by governments and private organizations to develop many topical drugs are driving the growth of the market. Additionally, the growing number of approvals for dermatology products is boosting the growth of the market. For instance, pharmaceutical company AbbVie Inc. announced that the U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of patients with active psoriatic arthritis in December 2021. Though, the increasing presence of acne treatment alternatives such as light or laser therapy, micro-needling, chemical peels, microdermabrasion, and lesion removal is anticipated to restrain the growth of the dermatology market during the forecast period 2023-2030.

Opportunities

  • Increasing Cases of Skin Disorders

The increasing frequency of skin cancer and other associated skin disorders or other skin issues such as vitiligo, acne, and dermatosis combined with the growing demand of effective drugs are the most major factors increasing the growth for this market. Furthermore, fungal infection and acne were more incident in the adolescent age group, accounting for around 17.4% and 30.4%, respectively. Around 84.5 million Americans, one in four, were largely impacted by skin disease. It has been seen that acne is the most common skin condition in the U.S., affecting more than 50 million Americans each year. Acne typically begins in puberty and affects various adolescents and young adults. As per the records of the World Psoriasis Day consortium, around 125 million people globally which means that 2 to 3% of the total population suffer from psoriasis. Therefore, this boosts the market growth. 

Restraints/Challenges

  • High Cost of Drugs

There are numerous drugs that are related with the disease such as targeted therapy and chemotherapy. The targeted therapy drugs include proteasome inhibitor, such as bortezomib, and various other compounds, including dexamethasone, prednisone, and thalidomide. These drugs process causes the increased rate of cost. Thus, these factors restrict the market growth.

This topical derma drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical derma drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

U.S. Topical Derma Drugs Market Scope

The topical derma drugs market is segmented on the basis of severity, drug class, formulation, site, application, population type, mode of purchase, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Severity

  • Mild to Moderate
  • Moderate to Severe

Drug Class

  • Anti-Fungal
  • Corticosteroids
  • Local Anaesthetics
  • Anti-Virals
  • Antibiotics
  • Anti-Acne Agents
  • Anti-Itch Agents
  • Miscellaneous Topical Agents
  • Others

Formulation

  • Patches
  • Gel
  • Ointment
  • Cream
  • Foams
  • Others

Site

  • Surface of the Skin
  • Epidermis and Dermis

Application

  • Acne
  • Cold Sores
  • Hives
  • Actinic Keratosis
  • Carbuncle
  • Rosacea
  • Eczema
  • Psoriasis
  • Lupus
  • Contact Dermatitis
  • Vitiligo
  • Warts
  • Ringworm
  • Impetigo
  • Others

Population Type

  • Children
  • Adults

Mode of Purchase

  • Prescription
  • Over the Counter (OTC)

End User

  • Hospitals
  • Specialty Clinics
  • Academic & Research Institutes
  • Others

Competitive Landscape and U.S. Topical Derma Drugs Market Share Analysis

The topical derma drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, U.S. presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical derma drugs market.

Key players operating in the topical derma drugs market include:

  • Sanofi (France)
  • Novartis AG (Switzerland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer Inc. (U.S.)
  • Sanofi (France)
  • Amgen inc. (U.S.)
  • Lilly (U.S.)
  • AstraZeneca (U.K.)
  • AbbVie Inc (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • LEO Pharma A/S (Denmark)
  • Merck & Co., Inc (U.S.)
  • Bausch Health Companies Inc (Canada)
  • Bristol-Myers Squibb Company (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The U.S. Topical Derma Drugs Market is projected to grow at a CAGR of 9.0% during the forecast period by 2030.
The future market value of the U.S. Topical Derma Drugs Market is expected to reach USD 9.37 billion by 2030.
The major players in the U.S. Topical Derma Drugs Market are Sanofi (France), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Amgen inc. (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), etc.
The countries covered in the U.S. Topical Derma Drugs Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials